Among self-reported African-descended breast cancer patients, 24.1% (28 of 116) carried 29 pathogenic variants in ATM, BARD1, BRCA1, BRCA2, BRIP1, FAM175A, FANCM, PALB2 and TP53 genes. This evidence concerns the gene PALB2 and breast carcinoma.